Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study Analysis

Identifier:  imarina:9231550

Handle: https://hdl.handle.net/20.500.11797/imarina9231550

Authors:  Barca-Hernando, Maria; Munoz-Martin, Andres J.; Rios-Herranz, Eduardo; Garcia-Escobar, Ignacio; Beato, Carmen; Font, Carme; Oncala-Sibajas, Estefania; Revuelta-Rodriguez, Alfonso; Areses, Maria Carmen; Rivas-Jimenez, Victor; Ballaz-Quincoces, Aitor; Moreno-Santos, Maria Angeles; Lopez-Saez, Juan-Bosco; Gallego-Gallego, Iria; Elias-Hernandez, Teresa; Asensio-Cruz, Maria Isabel; Chasco-Eguilaz, Leyre; Garcia-Gonzalez, Gonzalo; Estevez-Garcia, Purificacion; Marin-Barrera, Lucia; Otero-Candelera, Remedios; Lopez-Ruz, Sergio; Lima-Alvarez, Jorge; Sanchez-Diaz, Jose Maria; Real-Dominguez, Macarena; Borrego-Delgado, Maria Carmen; Marin-Romero, Samira; Jara-Palomares, Luis

Abstract:
Simple SummaryThe impact of anemia on the quality of life (QoL) in cancer patients has been studied previously; however, the cut-off point used to define anemia differed among studies, thus providing inconsistent results. Therefore, we analysed the clinical impact of anemia on QoL using the same cut-off point for hemoglobin level to define anemia as that used in ESMO clinical practice guidelines. This post-hoc analysis aimed to determine the impact of anemia on QoL in cancer patients through the European Organization for Research and Treatment of Cancer Quality of life questionnaire version 3.0 (EORTC QLQ-C30) and Euro QoL 5-dimension 3-level (EQ-5D-3L) questionnaire. We found that cancer patients with anemia had significantly worse QoL in clinical terms. In addition, anemic patients had more pronounced symptoms than those in non-anemic patients.Anemia is a common condition in cancer patients and is associated with a wide variety of symptoms that impair quality of life (QoL). However, exactly how anemia affects QoL in cancer patients is unclear because of the inconsistencies in its definition in previous reports. We aimed to examine the clinical impact of anemia on the QoL of cancer patients using specific questionnaires. We performed a post-hoc analysis of a multicenter, prospective, case-control study. We included patients with cancer with (cases) or without (controls) anemia. Participants completed the European Organization for Research and Treatment of Cancer Quality of Life questionnaire version 3.0 (EORTC QLQ-C30) and Euro QoL 5-dimension 3-level (EQ-5D-3L) questionnaire. Statistically significant and clinically relevant differences in the global health status were examined. From 2015 to 2018, 365 patients were included (90 cases and 275 controls). We found minimally important differences in global health status according to the EORTC QLQ-C30 questionnaire (case vs. controls: 45.6 vs. 58%, respectively; mean difference: -12.4, p < 0.001). Regarding symptoms, cancer patients with anemia had more pronounced symptoms in six out of nine scales in comparison with those without anemia. In conclusion, cancer patients with anemia had a worse QoL both clinically and statistically.